Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Voon Ong

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Annals of the Rheumatic Diseases|February 10, 2026
Engaging the PD-1 pathway in systemic sclerosis attenuates inflammation-driven fibrosisMaithri Aspari, Voon Ong, Klaus Søndergaard, et al.
The International Journal of Biochemistry & Cell Biology|March 4, 2021
Selective deletion of connective tissue growth factor attenuates experimentally-induced pulmonary fibrosis and pulmonary arterial hypertensionAngela Y Y Tam, Amy L Horwell, Sarah L Trinder, et al.
Journal of Scleroderma and Related Disorders|June 8, 2018
Reliability of digital ulcer definitions as proposed by the UK Scleroderma Study Group: A challenge for clinical trial designMichael Hughes, Andrew Tracey, Monica Bhushan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 13, 2025
Critical Role for Transglutaminase 2 in Scleroderma Skin Fibrosis and in the Development of Dermal Sclerosis in a Mouse Model of SclerodermaAngela Y Y Tam, Korsa Khan, Shiwen Xu, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 2010
6-Benzylamino 4-oxo-1,4-dihydro-1,8-naphthyridines and 4-oxo-1,4-dihydroquinolines as HIV integrase inhibitorsJohnny Y Nagasawa, Jenny Song, Huanming Chen, et al.
Frontiers in Immunology|February 18, 2026
Systemic sclerosis-associated pulmonary arterial hypertension and pulmonary fibrosis: exploring biomarker discriminators with advanced omics in a Caucasian cohortNada Mohamed-Ali, Vanessa Acquaah, Maneera Al-Jaber, et al.
The FEBS Journal|July 7, 2025
Multi-omic analysis identifies biological processes underlying progressive interstitial lung disease in systemic sclerosisSelena Bouffette, Perrine Soret, Alice Cole, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 21, 2010
RG3487, a novel nicotinic α7 receptor partial agonist, improves cognition and sensorimotor gating in rodentsTanya L Wallace, Patrick M Callahan, Ashok Tehim, et al.
Rheumatology (Oxford, England)|September 22, 2018
European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosisGiuseppina Abignano, Jelena Blagojevic, Lesley-Anne Bissell, et al.
Clinical Rheumatology|January 10, 2020
Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung diseaseCarmel J W Stock, Angelo De Lauretis, Dina Visca, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Annals of the Rheumatic Diseases|February 10, 2026
Engaging the PD-1 pathway in systemic sclerosis attenuates inflammation-driven fibrosisMaithri Aspari, Voon Ong, Klaus Søndergaard, et al.
The International Journal of Biochemistry & Cell Biology|March 4, 2021
Selective deletion of connective tissue growth factor attenuates experimentally-induced pulmonary fibrosis and pulmonary arterial hypertensionAngela Y Y Tam, Amy L Horwell, Sarah L Trinder, et al.
Journal of Scleroderma and Related Disorders|June 8, 2018
Reliability of digital ulcer definitions as proposed by the UK Scleroderma Study Group: A challenge for clinical trial designMichael Hughes, Andrew Tracey, Monica Bhushan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 13, 2025
Critical Role for Transglutaminase 2 in Scleroderma Skin Fibrosis and in the Development of Dermal Sclerosis in a Mouse Model of SclerodermaAngela Y Y Tam, Korsa Khan, Shiwen Xu, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 2010
6-Benzylamino 4-oxo-1,4-dihydro-1,8-naphthyridines and 4-oxo-1,4-dihydroquinolines as HIV integrase inhibitorsJohnny Y Nagasawa, Jenny Song, Huanming Chen, et al.
Frontiers in Immunology|February 18, 2026
Systemic sclerosis-associated pulmonary arterial hypertension and pulmonary fibrosis: exploring biomarker discriminators with advanced omics in a Caucasian cohortNada Mohamed-Ali, Vanessa Acquaah, Maneera Al-Jaber, et al.
The FEBS Journal|July 7, 2025
Multi-omic analysis identifies biological processes underlying progressive interstitial lung disease in systemic sclerosisSelena Bouffette, Perrine Soret, Alice Cole, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 21, 2010
RG3487, a novel nicotinic α7 receptor partial agonist, improves cognition and sensorimotor gating in rodentsTanya L Wallace, Patrick M Callahan, Ashok Tehim, et al.
Rheumatology (Oxford, England)|September 22, 2018
European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosisGiuseppina Abignano, Jelena Blagojevic, Lesley-Anne Bissell, et al.
Clinical Rheumatology|January 10, 2020
Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung diseaseCarmel J W Stock, Angelo De Lauretis, Dina Visca, et al.
Pageof 5